Video

Q&A With Zobair Younossi From Inova Fairfax Hospital: Hepatitis C Treatment Provides Fiscal Benefits as Well as Health Improvements

Author(s):

As hepatitis C becomes a curable condition in many parts of the world research is also showing the financial benefits of allowing once sick patients to resume their normal lives after treatment.

As hepatitis C becomes a curable condition in many parts of the world research is also showing the financial benefits of allowing once sick patients to resume their normal lives after treatment.

Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, from Inova Fairfax Hospital discussed what the advancements in treatment have meant to helping improve quality of life for patients and what work remains to be done during Digestive Disease Week in Washington DC. Younossi said even as recently as 5 years ago he could not have predicted how far treatment would have come and looks forward to seeing the condition's status in 5 more years.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.